Publications by authors named "J L Demory"

Claim this Profile
I
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.
Yan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, Marta Sobas, Parvis Sadjadian, Jean-Loup Demory

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs.
Marta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, Natalia Curto-Garcia, Parvis Sadjadian, Jean-Loup Demory

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.
Jean-Christophe Ianotto, Aurélie Chauveau, Françoise Boyer-Perrard, Emmanuel Gyan, Kamel Laribi, Jean-Loup Demory

Haematologica· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.
Agnès Charpentier, Aurélien Lebreton, Antoine Rauch, Anne Bauters, Nathalie Trillot, Jean-Loup Demory

Haematologica· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coherent manipulation of a solid-state artificial atom with few photons.
V Giesz, N Somaschi, G Hornecker, T Grange, B Reznychenko, J Demory

Nat Commun· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis